Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

BACKGROUND: The incidence and severity of tuberculosis chemotherapy toxicity is poorly characterised. We used data available from patients in the REMoxTB trial to provide an assessment of the risks associated with the standard regimen and two experimental regimens containing moxifloxacin. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Tweed, Conor D., Crook, Angela M., Amukoye, Evans I., Dawson, Rodney, Diacon, Andreas H., Hanekom, Madeline, McHugh, Timothy D., Mendel, Carl M., Meredith, Sarah K., Murphy, Michael E., Murthy, Saraswathi E., Nunn, Andrew J., Phillips, Patrick P. J., Singh, Kasha P., Spigelman, Melvin, Wills, Genevieve H., Gillespie, Stephen H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042413/
https://www.ncbi.nlm.nih.gov/pubmed/29996783
http://dx.doi.org/10.1186/s12879-018-3230-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042413/
https://www.ncbi.nlm.nih.gov/pubmed/29996783
http://dx.doi.org/10.1186/s12879-018-3230-6

Ejemplares similares